Medical Oddities: Pig Semen, Meet Eye Drops - Scorecard - MDSpire

Medical Oddities: Pig Semen, Meet Eye Drops

  • By

  • Teraya Smith

  • April 1, 2026

  • 6 min

Share

Clinical Scorecard: Medical Oddities: Pig Semen, Meet Eye Drops

At a Glance

CategoryDetail
ConditionRetinoblastoma
Key MechanismsUse of porcine semen-derived exosomes to enhance drug delivery to the retina.
Target PopulationPatients with retinoblastoma.
Care SettingOphthalmology clinics and research settings.

Key Highlights

  • Porcine-derived exosomes achieved 14% corneal penetration compared to 2% for free drug.
  • FA-SEVs@CMG platform inhibited 83% of tumor cells in vitro.
  • In vivo treatment reduced retinoblastoma burden to 2.35% of control levels.
  • Treatment mechanisms included oxidative stress, ferroptosis, and apoptosis.
  • Minimal toxicity and inflammation observed with the eye drop formulation.

Guideline-Based Recommendations

Diagnosis

  • Utilize advanced imaging techniques for accurate diagnosis of retinoblastoma.

Management

  • Consider novel drug delivery systems like exosome-based therapies for treatment.

Monitoring & Follow-up

  • Regular follow-up to assess retinal function and tumor response.

Risks

  • Monitor for potential ocular toxicity and inflammation from novel therapies.

Patient & Prescribing Data

Patients diagnosed with retinoblastoma requiring innovative treatment options.

Exosome-based eye drops may offer a promising alternative to traditional therapies.

Clinical Best Practices

  • Incorporate multidisciplinary approaches in managing retinoblastoma.
  • Stay updated on emerging therapies and their clinical implications.

References

Original Source(s)

Related Content